PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
C.H. Arrowsmith(University Health Network), Mathieu Lupien(Ontario Institute for Cancer Research), Jocelyn Chen(University Health Network), Benjamin Haibe‐Kains(University of Toronto), Jennifer Cruickshank(Ontario Institute for Cancer Research), YiShuai Ji(Zhejiang Cancer Hospital), Sajid A. Marhon(University of Pennsylvania), Jillian Haight(University Health Network), Katlin B. Massirer(Universidade Estadual de Campinas (UNICAMP)), Jing Liu(Sichuan University), Dalia Baršytė-Lovejoy(University Health Network), Lan-Xin Zhang(University of Toronto), Magdalena M. Szewczyk(University of Toronto), Shili Duan(Ontario Institute for Cancer Research), Wail Ba-alawi(University Health Network), Jian Jin(Icahn School of Medicine at Mount Sinai), Nergiz Doğan(University Health Network), David W. Cescon(Princess Margaret Hospital), Wenjun Chen(University of Toronto), Panagiotis Prinos(University of Toronto), Daniel D. De Carvalho(University Health Network), Xiaojia Wang(Zhejiang Cancer Hospital), Geneviève Deblois(Institute for Research in Immunology and Cancer), Felipe E. Ciamponi(Universidade Estadual de Campinas (UNICAMP)), ZiWen Zhang(Zhejiang Cancer Hospital), Parinaz Mehdipour(University Health Network), Yudao Shen(Icahn School of Medicine at Mount Sinai)
Cited by 124
Related Papers
Epigenetic protein families: a new frontier for drug discovery
|Nature Reviews Drug Discovery|2012|1.3k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848